Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves over-expression of Cyr61.

Lee YJ, Lee DM, Lee CH, Heo SH, Won SY, Im JH, Cho MK, Nam HS, Lee SH.

Toxicol In Vitro. 2011 Feb;25(1):199-205. doi: 10.1016/j.tiv.2010.10.020. Epub 2010 Nov 3.

PMID:
21055460
2.

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.

Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML.

J Biol Chem. 2004 Jun 4;279(23):24015-23. Epub 2004 Mar 24.

3.

Signaling pathways involved in antioxidant control of glioma cell proliferation.

Martín V, Herrera F, García-Santos G, Antolín I, Rodriguez-Blanco J, Rodriguez C.

Free Radic Biol Med. 2007 Jun 1;42(11):1715-22. Epub 2007 Mar 12.

PMID:
17462539
4.

Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.

Lampiasi N, Azzolina A, D'Alessandro N, Umezawa K, McCubrey JA, Montalto G, Cervello M.

Mol Pharmacol. 2009 Aug;76(2):290-300. doi: 10.1124/mol.109.055418. Epub 2009 May 20.

5.

Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.

Lee YJ, Lee DM, Lee SH.

Food Chem Toxicol. 2013 Aug;58:169-76. doi: 10.1016/j.fct.2013.04.035. Epub 2013 Apr 24.

PMID:
23623839
7.

Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species.

Koka PS, Mondal D, Schultz M, Abdel-Mageed AB, Agrawal KC.

Exp Biol Med (Maywood). 2010 Jun;235(6):751-60. doi: 10.1258/ebm.2010.009369.

PMID:
20511679
8.
9.

DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase.

Liu J, Yoshida Y, Yamashita U.

Mol Immunol. 2008 Sep;45(15):3984-9. doi: 10.1016/j.molimm.2008.06.012. Epub 2008 Jul 25.

PMID:
18657320
10.
11.

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.

Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.

Clin Cancer Res. 2007 Apr 1;13(7):2236-45.

12.
13.

Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells.

Finn NA, Kemp ML.

Mol Biosyst. 2012 Feb;8(2):650-62. doi: 10.1039/c1mb05315a. Epub 2011 Dec 1.

14.
15.

The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.

Chin KL, Aerbajinai W, Zhu J, Drew L, Chen L, Liu W, Rodgers GP.

Br J Haematol. 2008 Nov;143(3):421-32. doi: 10.1111/j.1365-2141.2008.07368.x. Epub 2008 Sep 1.

PMID:
18764868
16.

A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.

Liu H, Chen A, Guo F, Yuan L.

Cancer Lett. 2010 Sep 1;295(1):27-37. doi: 10.1016/j.canlet.2010.02.012. Epub 2010 Mar 6.

PMID:
20207476
17.

N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.

Araki S, Dobashi K, Kubo K, Yamamoto Y, Asayama K, Shirahata A.

Life Sci. 2006 Nov 17;79(25):2405-12. Epub 2006 Aug 16.

PMID:
16952378
18.

A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.

Shanmugam R, Kusumanchi P, Cheng L, Crooks P, Neelakantan S, Matthews W, Nakshatri H, Sweeney CJ.

Prostate. 2010 Jul 1;70(10):1074-86. doi: 10.1002/pros.21141.

PMID:
20209491
19.

ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.

Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S.

Circ Res. 2001 Oct 12;89(8):661-9.

20.

Supplemental Content

Support Center